6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine

C99H82F10N26O6 — CID 158707673

IUPAC6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine
SMILESCCn1nc(C)c(-c2cncc(Nc3ccc(OC(F)(F)F)cc3)n2)c1C.COc1ccc(Nc2cncc(-c3cccc4nc(C5CC5)cn34)n2)cc1.Cc1nc2ncccc2n1-c1cncc(Nc2ccc(OC(F)F)cc2)n1.FC(F)(F)Oc1ccc(Nc2cncc(-c3cccc4nc(C5CC5)cn34)n2)cc1.FC1(F)Oc2ccc(Nc3cncc(-c4cccc5nc(C6CC6)cn45)n3)cc2O1
InChIInChI=1S/C21H16F3N5O.C21H15F2N5O2.C21H19N5O.C18H18F3N5O.C18H14F2N6O/c22-21(23,24)30-15-8-6-14(7-9-15)26-19-11-25-10-16(27-19)18-2-1-3-20-28-17(12-29(18)20)13-4-5-13;22-21(23)29-17-7-6-13(8-18(17)30-21)25-19-10-24-9-14(26-19)16-2-1-3-20-27-15(11-28(16)20)12-4-5-12;1-27-16-9-7-15(8-10-16)23-20-12-22-11-17(24-20)19-3-2-4-21-25-18(13-26(19)21)14-5-6-14;1-4-26-12(3)17(11(2)25-26)15-9-22-10-16(24-15)23-13-5-7-14(8-6-13)27-18(19,20)21;1-11-23-17-14(3-2-8-22-17)26(11)16-10-21-9-15(25-16)24-12-4-6-13(7-5-12)27-18(19)20/h1-3,6-13H,4-5H2,(H,26,27);1-3,6-12H,4-5H2,(H,25,26);2-4,7-14H,5-6H2,1H3,(H,23,24);5-10H,4H2,1-3H3,(H,23,24);2-10,18H,1H3,(H,24,25)
InChIKeyIIHYUBZWVHUEEJ-UHFFFAOYSA-N
MW1921.90 g/mol
LogP22.95
Rot. Bonds24

About 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine

6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine (PubChem CID 158707673) has the molecular formula C99H82F10N26O6 and a molecular weight of 1921.90 g/mol. Its IUPAC name is 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine.

Molecular Properties

Compound Name6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine
PubChem CID158707673
Molecular FormulaC99H82F10N26O6
Molecular Weight1921.90 g/mol
Exact Mass1920.68
IUPAC Name6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine
SMILESCCn1nc(C)c(-c2cncc(Nc3ccc(OC(F)(F)F)cc3)n2)c1C.COc1ccc(Nc2cncc(-c3cccc4nc(C5CC5)cn34)n2)cc1.Cc1nc2ncccc2n1-c1cncc(Nc2ccc(OC(F)F)cc2)n1.FC(F)(F)Oc1ccc(Nc2cncc(-c3cccc4nc(C5CC5)cn34)n2)cc1.FC1(F)Oc2ccc(Nc3cncc(-c4cccc5nc(C6CC6)cn45)n3)cc2O1
InChIInChI=1S/C21H16F3N5O.C21H15F2N5O2.C21H19N5O.C18H18F3N5O.C18H14F2N6O/c22-21(23,24)30-15-8-6-14(7-9-15)26-19-11-25-10-16(27-19)18-2-1-3-20-28-17(12-29(18)20)13-4-5-13;22-21(23)29-17-7-6-13(8-18(17)30-21)25-19-10-24-9-14(26-19)16-2-1-3-20-27-15(11-28(16)20)12-4-5-12;1-27-16-9-7-15(8-10-16)23-20-12-22-11-17(24-20)19-3-2-4-21-25-18(13-26(19)21)14-5-6-14;1-4-26-12(3)17(11(2)25-26)15-9-22-10-16(24-15)23-13-5-7-14(8-6-13)27-18(19,20)21;1-11-23-17-14(3-2-8-22-17)26(11)16-10-21-9-15(25-16)24-12-4-6-13(7-5-12)27-18(19)20/h1-3,6-13H,4-5H2,(H,26,27);1-3,6-12H,4-5H2,(H,25,26);2-4,7-14H,5-6H2,1H3,(H,23,24);5-10H,4H2,1-3H3,(H,23,24);2-10,18H,1H3,(H,24,25)
InChIKeyIIHYUBZWVHUEEJ-UHFFFAOYSA-N
XLogP22.95
TPSA344.86 Ų
H-Bond Donors5
H-Bond Acceptors32
Rotatable Bonds24
Heavy Atoms141
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001921.90
LogP ≤ 522.95
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1032

Analyze 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine?
The IUPAC name of 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine (CID 158707673) is 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine.
What is the SMILES notation for 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine?
The canonical SMILES for 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine is CCn1nc(C)c(-c2cncc(Nc3ccc(OC(F)(F)F)cc3)n2)c1C.COc1ccc(Nc2cncc(-c3cccc4nc(C5CC5)cn34)n2)cc1.Cc1nc2ncccc2n1-c1cncc(Nc2ccc(OC(F)F)cc2)n1.FC(F)(F)Oc1ccc(Nc2cncc(-c3cccc4nc(C5CC5)cn34)n2)cc1.FC1(F)Oc2ccc(Nc3cncc(-c4cccc5nc(C6CC6)cn45)n3)cc2O1.
What is the InChIKey of 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine?
The InChIKey is IIHYUBZWVHUEEJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H16F3N5O.C21H15F2N5O2.C21H19N5O.C18H18F3N5O.C18H14F2N6O/c22-21(23,24)30-15-8-6-14(7-9-15)26-19-11-25-10-16(27-19)18-2-1-3-20-28-17(12-29(18)20)13-4-5-13;22-21(23)29-17-7-6-13(8-18(17)30-21)25-19-10-24-9-14(26-19)16-2-1-3-20-27-15(11-28(16)20)12-4-5-12;1-27-16-9-7-15(8-10-16)23-20-12-22-11-17(24-20)19-3-2-4-21-25-18(13-26(19)21)14-5-6-14;1-4-26-12(3)17(11(2)25-26)15-9-22-10-16(24-15)23-13-5-7-14(8-6-13)27-18(19,20)21;1-11-23-17-14(3-2-8-22-17)26(11)16-10-21-9-15(25-16)24-12-4-6-13(7-5-12)27-18(19)20/h1-3,6-13H,4-5H2,(H,26,27);1-3,6-12H,4-5H2,(H,25,26);2-4,7-14H,5-6H2,1H3,(H,23,24);5-10H,4H2,1-3H3,(H,23,24);2-10,18H,1H3,(H,24,25).
What are the key properties of 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine?
6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine has a molecular weight of 1921.90 g/mol, XLogP of 22.95, 24 rotatable bonds, 5 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(2-cyclopropylimidazo[1,2-a]pyridin-5-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-(2-methylimidazo[4,5-b]pyridin-1-yl)pyrazin-2-amine;6-(1-ethyl-3,5-dimethylpyrazol-4-yl)-N-[4-(trifluoromethoxy)phenyl]pyrazin-2-amine is sourced from PubChem (CID 158707673), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).